Prognostic implication of creatine kinase elevation following elective coronary artery interventions

JAMA

Volumn 277, Issue 6, 1997, Pages 461-466

  Kong, Thomas Q ^a   Davidson, Charles J ^a,b   Meyers, Sheridan N ^a   Tauke, Jason T ^a   Parker, Michele A ^a   Bonow, Robert O ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 1842293989     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.6.461     Document Type: Article

References (18)

1. Detre KD, Holubkov R, Kelsey S, et al, and the Co-investigators of the National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. N Engl J Med. 1988;318:265-270.
2. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty, J Am Coll Cardiol. 1991;17:621-626.
3. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 1993;329:221-227.
4. Holmes DR, Topol EJ, Califf RM, et al, for the CAVEAT-II Investigators. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation. 1995;91:1966-1974.
5. Adelman AG, Cohen EA, Kimball BP, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 1993;329:228-233.
6. Kugelmass AD, Cohen DJ, Moscucci M, et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 1994;74:748-754.
7. Ravkilde J, Nissen H, Mickley H, Andersen PE, Thayssen P, Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J. 1994;127:13-20.
8. Leon MB, Popma JJ, Kuntz RE, et al, for the Optimal Atherectomy Restenosis Study (OARS) Investigators. Acute angiographic and ultrasound results of directional atherectomy in OARS. Circulation. 1994;90(suppl 1):I-213. Abstract.
9. Baim DS, Kuntz RE, Pompa JJ, Leon MB, Ho KKL, for the BOAT Investigators. Results of directional atherectomy in the 'pilot' phase of BOAT. Circulation. 1994;90(suppl 1):I-214. Abstract.
10. Oh JK, Shub CS, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985;109:1225-1231.
11. Waksman R, Scott NA, Douglass JS, Mays R, Yee-Petersen J, King SB. Distal embolization is common after directional atherectomy in coronary arteries and vein grafts. Circulation. 1993;88(suppl 1):I-299. Abstract.
12. Elliott JM, Berdan LG, Holmes DR, et al, for the CAVEAT Study Investigators. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I). Circulation. 1995; 91:2158-2166.
13. Ellis SG, Vandormael MG, Cowley MJ, et al, and the Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation. 1990;82: 1193-1202.
14. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Circulation. 1994;89:2015-2025.
15. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation. 1987;76:142-154.
16. Hosmer DW, Lemeshow S. Interpretation of coefficients. In: Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989:74-76.
17. Abdelmeguid AE, Whitlow PL, Sapp SK, Ellis SG, Topol EJ. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation. 1995;91:2733-2741.
18. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.